Home Cart Sign in  
Chemical Structure| 526-08-9 Chemical Structure| 526-08-9

Structure of Sulfaphenazole
CAS No.: 526-08-9

Chemical Structure| 526-08-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sulfaphenazole is a sulfonamide antibacterial and a specific inhibitor of CYP2C9.

Synonyms: Depocid; Depotsulfonamide; Inamil

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sulfaphenazole

CAS No. :526-08-9
Formula : C15H14N4O2S
M.W : 314.36
SMILES Code : O=S(C1=CC=C(N)C=C1)(NC2=CC=NN2C3=CC=CC=C3)=O
Synonyms :
Depocid; Depotsulfonamide; Inamil
MDL No. :MFCD00057226
InChI Key :QWCJHSGMANYXCW-UHFFFAOYSA-N
Pubchem ID :5335

Safety of Sulfaphenazole

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
661W cells 10 μM 4 hours To screen for cytoprotective compounds against light-induced cell death, Sulfaphenazole was identified as a novel cytoprotective compound. PMC3961660
RAW264.7 macrophages 2.5 μM 30 minutes To examine the role of cytochrome P450s (CYPs) on the metabolism of selenocoxib-2, it was found that sulphaphenazole effectively inhibited the release of Se from selenocoxib-2 PMC3004533
661W cells 0.625–100 μM 4–6 hours To validate the cytoprotection of Sulfaphenazole, results showed a dose-dependent increase in cellular ATP, demonstrating better cytoprotective performance and durability than minocycline and L-sulforaphane. PMC3961660

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Swiss Webster mice Hypoxia-induced pulmonary hypertension model Intraperitoneal injection 5 mg/kg Once daily for 3 days To assess the effect of sulfaphenazole on CYP2C9 overexpression-induced pulmonary hypertension PMC1993904
Rat Langendorff isolated perfused rat heart model Perfusion 10–300 μM 20 min before ischemia or at reperfusion Reduction in creatine kinase release and infarct size PMC337051
Mice ENOS-deficient mice Intracoronary infusion 10 μM Single dose, 10 minutes To investigate the effect of Sulfaphenazole on BK-induced vasodilation, results showed no significant effect on BK-induced vasodilation in both WT and eNOS-deficient mouse hearts. PMC1573164
ApoE−/− mice Thermal injury and I/R-mediated pressure injury model Intraperitoneal injection 5.13 mg/kg Once daily for 15 days (thermal injury) or 14 days (pressure injury) SP reduced thermal and pressure injury severity through rapid restoration of tissue perfusion, improved wound closure, increased wound tensile strength, decreased tissue hypoxia, inflammation, and fibrosis, and enhanced M1 macrophage activity. PMC9308818

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.18mL

0.64mL

0.32mL

15.91mL

3.18mL

1.59mL

31.81mL

6.36mL

3.18mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories